Triage Medical’s Bio-Clasp
This article was originally published in The Gray Sheet
Executive Summary
Compression locking anchor technology gains 510(k) clearance for use in fixating bone fractures. The technology has greater compressive strength compared to firm's current line of Bone-Lok devices, especially for osteoporotic bone. Triage projects a $700 mil. market potential and it will adapt Bio-Clasp for the spine, hip and hand...
You may also be interested in...
Scrip M&A Podcast: Which Companies Could Be Acquired Next?
The editorial team from Scrip discusses the M&A potential of various emerging biopharmas, such as Viking, Verona, Altimmune, Xenon and Crinetics.
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.
P&G Restores Volume Growth In Beauty, Grooming After Pricing Run
Procter & Gamble reports strong consumer spending in the US and Europe after a 3% increase in product pricing over the past year. Dragging on fiscal third-quarter results, sales of SK-II in China fell 30% for the January-March period, while lower incidence of cough and cold impacted Health Care performance.